Explore
Validate
LearnTA323326
antibody from OriGene
Targeting: NLRP3
AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, DFNA34, FCAS, FCU, MWS, NALP3, PYPAF1
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA323326 - Provider product page
- Provider
- OriGene
- Product name
- Anti-NLRP3 Rabbit Polyclonal Antibody
- Antibody type
- Polyclonal
- Description
- Anti-NLRP3 Rabbit Polyclonal Antibody
- Host
- Rabbit
- Conjugate
- Unconjugated
- Epitope
- NLRP3
- Isotype
- IgG
- Antibody clone number
- NULL
- Vial size
- 100 µl
- Concentration
- 0.6mg/ml
Submitted references Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
Tan CY, Weier Q, Zhang Y, Cox AJ, Kelly DJ, Langham RG
Nephron 2015;129(2):109-27
Nephron 2015;129(2):109-27
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Predicted cell location: Cytoplasm. Positive control: Human esophagus and thyroid cancer tissue. Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human esophagus cancer tissue using NLRP3 antibody at dilution 1/15, on the right is treated with the fusion protein. (Original magnification:x 200)
- Validation comment
- IHC
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Predicted cell location: Cytoplasm. Positive control: Human esophagus and thyroid cancer tissue. Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using NLRP3 antibody at dilution 1/15, on the right is treated with the fusion protein. (Original magnification:x200)
- Validation comment
- IHC
